Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2002 3
2005 1
2009 1
2010 6
2011 11
2012 11
2013 18
2014 22
2015 29
2016 36
2017 36
2018 56
2019 45
2020 38
2021 34
2022 22
2023 10
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 28889145

340 results

Results by year

Filters applied: . Clear all
Page 1
Another piece in the pirfenidone puzzle.
Lehmann M, Kolb M. Lehmann M, et al. Eur Respir J. 2023 Apr 27;61(4):2300240. doi: 10.1183/13993003.00240-2023. Print 2023 Apr. Eur Respir J. 2023. PMID: 37105587 No abstract available.
A randomized controlled phase III trial protocol: perioperative pirfenidone therapy in patients with non-small cell lung cancer combined with idiopathic pulmonary fibrosis to confirm the preventative effect against postoperative acute exacerbation: the PIII-PEOPLE study (NEJ034).
Sakairi Y, Yoshino I, Iwata T, Yoshida S, Kuwano K, Azuma A, Sakai S, Kobayashi K. Sakairi Y, et al. J Thorac Dis. 2023 Mar 31;15(3):1486-1493. doi: 10.21037/jtd-22-535. Epub 2023 Mar 6. J Thorac Dis. 2023. PMID: 37065585 Free PMC article.
Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose-response trial.
West A, Chaudhuri N, Barczyk A, Wilsher ML, Hopkins P, Glaspole I, Corte TJ, Šterclová M, Veale A, Jassem E, Wijsenbeek MS, Grainge C, Piotrowski W, Raghu G, Shaffer ML, Nair D, Freeman L, Otto K, Montgomery AB. West A, et al. Thorax. 2023 Sep;78(9):882-889. doi: 10.1136/thorax-2022-219391. Epub 2023 Mar 22. Thorax. 2023. PMID: 36948586 Free article. Clinical Trial.
Eligibility criteria from pharmaceutical randomised controlled trials of idiopathic pulmonary fibrosis: a registry-based study.
Khor YH, Schulte M, Johannson KA, Marcoux V, Fisher JH, Assayag D, Manganas H, Khalil N, Kolb M, Ryerson CJ; Austin ILD Registry and CARE-PF Investigators; ALLIANCE Study Group; Cox G, Fell CD, Gershon AS, Goh N, Halayko AJ, Lok S, Morisset J, Sadatsafavi M, Shapera S, To T, Wilcox PG, Wong AW. Khor YH, et al. Eur Respir J. 2023 May 5;61(5):2202163. doi: 10.1183/13993003.02163-2022. Print 2023 May. Eur Respir J. 2023. PMID: 36858445
Pirfenidone-induced photolichenoid drug eruption.
Dwivedi N, Witherspoon J, Yong-Gee S. Dwivedi N, et al. Australas J Dermatol. 2023 May;64(2):299-301. doi: 10.1111/ajd.14010. Epub 2023 Feb 20. Australas J Dermatol. 2023. PMID: 36808729 No abstract available.
340 results